Palisade Bio Stock Price on December 16, 2024
| PALI Stock | USD 1.90 0.06 3.26% |
Below is the normalized historical share price chart for Palisade Bio extending back to December 20, 2006. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Palisade Bio stands at 1.90, as last reported on the 18th of December 2024, with the highest price reaching 2.20 and the lowest price hitting 1.78 during the day.
If you're considering investing in Palisade Stock, it is important to understand the factors that can impact its price. Palisade Bio maintains Sharpe Ratio (i.e., Efficiency) of -0.0548, which implies the firm had a -0.0548% return per unit of risk over the last 3 months. Palisade Bio exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Palisade Bio's Risk Adjusted Performance of (0.03), coefficient of variation of (1,761), and Variance of 116.95 to confirm the risk estimate we provide.
As of now, Palisade Bio's Common Stock Shares Outstanding is increasing as compared to previous years. The Palisade Bio's current Other Stockholder Equity is estimated to increase to about 140.2 M, while Total Stockholder Equity is projected to decrease to under 6.2 M. . The current Price To Sales Ratio is estimated to decrease to 17.64. The current Price Earnings Ratio is estimated to decrease to -0.34. Palisade Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 20th of December 2006 | 200 Day MA 4.2758 | 50 Day MA 2.7748 | Beta 1.331 |
Palisade |
Sharpe Ratio = -0.0548
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PALI |
Estimated Market Risk
| 11.05 actual daily | 96 96% of assets are less volatile |
Expected Return
| -0.61 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.05 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Palisade Bio is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Palisade Bio by adding Palisade Bio to a well-diversified portfolio.
Price Book 0.4775 | Enterprise Value Ebitda 0.5714 | Price Sales 14.0311 | Shares Float 1.2 M | Wall Street Target Price 30.3333 |
Related Headline
Immix Biopharma Headline on 16th of December 2024
Journal of Clinical Oncology Publishes NXC-201 Positive Clin... by gurufocus.com
Chimeric antigen receptor T-cell cell therapy NXC-201 is a novel approach to treat relapsedrefractory AL Amyloidosis NXC-201 demonstrated compelling
Palisade Bio Valuation on December 16, 2024
It is possible to determine the worth of Palisade Bio on a given historical date. On December 16, 2024 Palisade was worth 1.59 at the beginning of the trading date compared to the closed value of 1.84. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Palisade Bio stock. Still, in general, we apply an absolute valuation method to find Palisade Bio's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Palisade Bio where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Palisade Bio's related companies.
| Open | High | Low | Close | Volume | |
| 2.24 | 2.35 | 1.70 | 1.77 | 1,945,744 | |
12/16/2024 | 1.59 | 1.99 | 1.59 | 1.84 | 763,094 |
| 1.99 | 2.20 | 1.78 | 1.90 | 666,595 |
| Backtest Palisade Bio | | | Palisade Bio History | | | Palisade Bio Valuation | Previous | Next |
Palisade Bio Trading Date Momentum on December 16, 2024
| On December 17 2024 Palisade Bio was traded for 1.90 at the closing time. The top price for the day was 2.20 and the lowest listed price was 1.78 . The trading volume for the day was 666.6 K. The trading history from December 17, 2024 was a factor to the next trading day price growth. The trading delta at closing time against the next closing price was 3.26% . The trading delta at closing time against the current closing price is 8.15% . |
Palisade Bio Fundamentals Correlations and Trends
By evaluating Palisade Bio's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Palisade Bio's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Palisade financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Palisade Bio Stock history
Palisade Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Palisade is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Palisade Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Palisade Bio stock prices may prove useful in developing a viable investing in Palisade Bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 456 K | 478.8 K | |
| Net Loss | -13.1 M | -13.7 M |
Palisade Bio Stock Technical Analysis
Palisade Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Palisade Bio Period Price Range
Low | December 18, 2024
| High |
0.00 | 0.00 |
Palisade Bio cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Palisade Bio December 18, 2024 Market Strength
Market strength indicators help investors to evaluate how Palisade Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Palisade Bio shares will generate the highest return on investment. By undertsting and applying Palisade Bio stock market strength indicators, traders can identify Palisade Bio entry and exit signals to maximize returns
Palisade Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Palisade Bio's price direction in advance. Along with the technical and fundamental analysis of Palisade Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Palisade to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.53) | |||
| Total Risk Alpha | (1.49) | |||
| Treynor Ratio | 0.4018 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Palisade Stock analysis
When running Palisade Bio's price analysis, check to measure Palisade Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Palisade Bio is operating at the current time. Most of Palisade Bio's value examination focuses on studying past and present price action to predict the probability of Palisade Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Palisade Bio's price. Additionally, you may evaluate how the addition of Palisade Bio to your portfolios can decrease your overall portfolio volatility.
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |